Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx
- PMID: 28662244
- PMCID: PMC5710281
- DOI: 10.1001/jamaoto.2017.0837
Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx
Abstract
Importance: Community-level socioeconomic status, particularly insurance status, is increasingly becoming important as a possible determinant in patient outcomes.
Objective: To determine the association of insurance and community-level socioeconomic status with outcome for patients with pharyngeal squamous cell carcinoma (SCC).
Design, setting, and participants: This study extracted data from more than 1500 Commission on Cancer-accredited facilities collected in the National Cancer Database. A total of 35 559 patients diagnosed with SCC of the pharynx from 2004 through 2013 were identified. The χ2 test, Kaplan-Meier method, and Cox regression models were used to analyze data from April 1, 2016, through April 16, 2017.
Main outcomes and measures: Overall survival was defined as time to death from the date of diagnosis.
Results: Among the 35 559 patients identified (75.6% men and 24.4% women; median age, 61 years [range, 18-90 years]), 15 146 (42.6%) had Medicare coverage; 13 061 (36.7%), private insurance; 4881 (13.7%), Medicaid coverage; and 2471 (6.9%), no insurance. Uninsured patients and Medicaid recipients were more likely to be younger, black, or Hispanic; to have lower median household income and lower educational attainment; to present with higher TNM stages of disease; and to start primary treatment at a later time from diagnosis. Those with private insurance (reference group) had significantly better overall survival than uninsured patients (hazard ratio [HR], 1.72; 95% CI, 1.59-1.87), Medicaid recipients (HR, 1.99; 95% CI, 1.88-2.12), or Medicare recipients (HR, 2.07; 95% CI, 1.99-2.16), as did those with median household income of at least $63 000 (reference) vs $48 000 to $62 999 (HR, 1.19; 95% CI, 1.13-1.26), $38 000 to $47 999 (HR, 1.31; 95% CI, 1.24-1.38), and less than $38 000 (HR, 1.51; 95% CI, 1.43-1.59). On multivariable analysis, insurance status and median household income remained independent prognostic factors for overall survival even after accounting for educational attainment, race, Charlson/Deyo comorbidity score, disease site, and TNM stage of disease.
Conclusions and relevance: Insurance status and household income level are associated with outcome in patients with SCC of the pharynx. Those without insurance and with lower household income may significantly benefit from improving access to adequate, timely medical care. Additional investigations are necessary to develop targeted interventions to optimize access to standard medical treatments, adherence to physician management recommendations, and subsequently, prognosis in these patients at risk.
Conflict of interest statement
Figures
Similar articles
-
The influence of insurance status on treatment and outcomes in oral cavity cancer: an analysis on 46,373 patients.Int J Oral Maxillofac Surg. 2018 Oct;47(10):1250-1257. doi: 10.1016/j.ijom.2018.03.022. Epub 2018 Apr 12. Int J Oral Maxillofac Surg. 2018. PMID: 29655817
-
Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma.Cancer Epidemiol. 2020 Aug;67:101723. doi: 10.1016/j.canep.2020.101723. Epub 2020 May 11. Cancer Epidemiol. 2020. PMID: 32408241
-
Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.J Neurooncol. 2017 Mar;132(1):89-98. doi: 10.1007/s11060-016-2339-y. Epub 2016 Nov 18. J Neurooncol. 2017. PMID: 27864706
-
Socioeconomic status as a determinant of survival in glioblastoma: a systematic review and meta-analysis.Neurosurg Rev. 2025 Jun 11;48(1):500. doi: 10.1007/s10143-025-03647-2. Neurosurg Rev. 2025. PMID: 40495036 Free PMC article.
-
Health Insurance and Diabetes.In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 42. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 42. PMID: 33651532 Free Books & Documents. Review.
Cited by
-
Regarding "Gaps in Treatment and Surveillance: Head and Neck Cancer Care in a Safety-Net Hospital".OTO Open. 2020 Jul 6;4(3):2473974X20938658. doi: 10.1177/2473974X20938658. eCollection 2020 Jul-Sep. OTO Open. 2020. PMID: 32671319 Free PMC article. No abstract available.
-
Survival outcomes and contributing factors in oral squamous cell carcinoma patients in Khuzestan province, southwest of Iran.Front Oncol. 2024 Dec 16;14:1472190. doi: 10.3389/fonc.2024.1472190. eCollection 2024. Front Oncol. 2024. PMID: 39737408 Free PMC article.
-
Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas.Eur J Cancer. 2024 May;202:113983. doi: 10.1016/j.ejca.2024.113983. Epub 2024 Mar 2. Eur J Cancer. 2024. PMID: 38452723 Free PMC article.
-
The Intersectionality between Race, Ethnicity, and Residential-Level Socioeconomic Status in Disparities of Head and Neck Cancer Outcomes: A SEER Study.Cancer Epidemiol Biomarkers Prev. 2023 Apr 3;32(4):516-523. doi: 10.1158/1055-9965.EPI-22-1167. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36780193 Free PMC article.
-
Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study.J Neurooncol. 2020 Jan;146(2):329-337. doi: 10.1007/s11060-019-03378-7. Epub 2019 Dec 27. J Neurooncol. 2020. PMID: 31883050 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30. - PubMed
-
- Berkovitz BK, Moxham BJ. Head and Neck Anatomy: A Clinical Reference. London, England: Martin Dunitz; 2002.
-
- Geara FB, Sanguineti G, Tucker SL, et al. . Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol. 1997;43(1):53-61. - PubMed
-
- Leung SF, Zee B, Ma BB, et al. . Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol. 2006;24(34):5414-5418. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous